29 June 2012
on course website
Pharmacoepidemiology & Drug Safety
With the prospect that innovative drug therapies will be introduced in the coming years, society demands new approaches and concepts for comparative risk/benefit evaluation. Assessment of safety and risk management of different drug therapies is done in the framework of observational epidemiological studies (proof of ‘safety’, proof of ‘effectiveness’). This is the logical next step after randomized clinical trials, which are designed to provide evidence of a drugs ‘efficacy’.
The course will cover key issues in pharmacoepidemiologic and drug safety research. Special topics include databases and molecular pharmacoepidemiology. Students will learn about the typical problems (e.g. confounding by indication, rare side effects) and approaches to deal with these problems in the practice of pharmacoepidemiology.
You will experience an intensive programme covering the following topics:
Study Design and Methods; Confounding and other biases; Methods in drug safety research; Drug Safety and Risk Management; Overview of Pharmacoepidemiological databases; Molecular Pharmacoepidemiology; Drug utilization research; Synthesis, case studies & public health
Dr. O.H. Klungel and Dr. T.P. van Staa
Postgraduates, clinicians and professionals within governments, industry, universities with a basic knowledge of epidemiology and an interest in pharmacoepidemiology and risk/benefit evaluation of drug therapies.
You will have a better understanding of:
- Study Design and Methods
- Confounding and other biases
- Methods in drug safety research
- Drug Safety and Risk Management
- Pharmacoepidemiological databases
- Molecular Pharmacoepidemiology
- Drug utilization research
Certificate of Attendance
EUR 1100: Course + course materials + housing
Utrecht Summer School doesn't offer scholarships for this course.Register for this course
on course website